新版医保目录发布，坚定支持“真创新”。展望 12 月:医保基金预付、积极推进商业保险，政策明显回暖，积极布局 2025 年。12 月重点推荐:药明康德、东阿阿胶、艾力斯、健友股份、贝达药业、诺泰生物、 亚盛医药、圣湘生物、九典制药、诺唯赞

根据 2024 年 11 月 28 日国家医保局公布的最新一期国家医保药品目录调整 结果，本次调整显著提升了药品保障水平，全面覆盖了新增药品类型，特别 关注肿瘤药、慢性病药及罕见病药。

近期国家医保局发布多项医改政策。医疗服务价格立项指南政策有助于推动AI辅助阅片、云胶片及部分新技术在医 疗机构中的应用。检查检查结果互认有助于减少重复检验检查，检查检验价格下调或影响部分医院的相关业务收入，部分医院 将主动控制设备采购成本，选择性价比更高的国产品牌，并为新技术、新设备、新耗材加快放量留出空间，继续看好创新能力 强、推进进口替代、国际化业务布局的国产医疗器械龙头投资机会。

本篇报告以血制品企业盈利模型的角度展开，即公司盈利=采浆量× 吨浆毛利-期间费用，同时考虑到集采风险、重组生物制品对血制品的替 代风险，逐项拆解，来洞察行业趋势及探究血制品企业的投资价值。

Multimodal imaging has revolutionized the field of medical diagnostics, offering clinicians a comprehensive view of anatomical structures and physiological processes through the integration of multiple imaging modalities. The concept of multimodal imaging dates to the early 20th century when pioneers in radiology began combining different imaging techniques to obtain complementary information about diseases and injuries. The advent of X-ray technology in the late 19th century laid the foundation for modern medical imaging, paving the way for innovations in magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear medicine.

The clinical data analytics market in healthcare is defined based on the revenues generated from the various solutions used in different end-use across the globe. The analysis is based on the market insights captured through secondary and primary research. The market also covers major factors impacting the growth of the market in terms of drivers and restraints. The scope of the study has been segmented based on the deployment type (cloud and on-premises), organization size (large enterprises, and small & medium enterprises (SMEs)), and end users (MedTech, pharmaceutical and life sciences, public health and government, and other end users (payers and providers) across the globe.

As per the scope of the report, poultry vaccines help prevent any particular disease by boosting the poultry animals’ immune system to produce antibodies, which fight against organisms.

Biocontrol agents are the organisms or microorganisms that control the plant pathogen in turf grass. The global turf grass biocontrol agent market is segmented by form and geography. The report offers market size and forecast by value (USD million) for the above segments.

The scope of the report includes the application of vitamins and amino acids in food and beverage, pharmaceuticals, and animal feed industries across the globe.

The uterine fibroids market (henceforth referred to as the market studied unless specified otherwise) is estimated to be USD 4,564.8 million in 2024. It is expected to reach USD 6,927.7 million by 2029, registering a CAGR of 8.7% from 2024 to 2029 (henceforth referred to as the forecast period).